Bimatoprost free acid impurity is a synthetic byproduct arising from the de-esterification of the parent drug's prodrug form. It retains the core cyclopentyl ring and conjugated diene system of bimatoprost but features a terminal carboxylic acid group instead of the ester moiety. This structural modification disrupts the lipophilic character of the parent compound, altering its pharmacokinetic profile. The compound serves as a critical HPLC reference standard for quantifying ester hydrolysis byproducts in bimatoprost API manufacturing processes.
On RequestC1[C@@H]([C@@H]([C@H]([C@@H]1O)/C=C/[C@H](CCC2=CC=CC=C2)O)C/C=C\CCCC(=O)O)O
InChI=1S/C23H32O5/c24-18(13-12-17-8-4-3-5-9-17)14-15-20-19(21(25)16-22(20)26)10-6-1-2-7-11-23(27)28/h1,3-6,8-9,14-15,18-22,24-26H,2,7,10-13,16H2,(H,27,28)/b6-1-,15-14+/t18-,19+,20+,21-,22+/m0/s1
YFHHIZGZVLHBQZ-KDACTHKWSA-N